Skip to main content
OpenTrials
Recruiting

NCT Number: NCT03775837

Effect of Panax Ginseng C.A. Mey Extract on Liver Function in Adults

The investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of Panax Ginseng C.A. Mey Extract on liver function in adults for 8 weeks.

Recruiting

Interested in participating?

Request Info

Key information

Age range

19 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Integrated Research Institute for Natural Ingredients and Functional Foods

Yangsan, 50612, South Korea

Location status: Recruiting

Location contact

Sang Yeoup Lee, MD

CONTACT

[email protected]

82-55-360-2860

About this study

Previous studies have indicated that Panax Ginseng C.A. Mey Extract may have the ability to improve liver function. Therefore, the investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of the Panax Ginseng C.A. Mey Extract on liver function in adults; the safety of the compound are also evaluate. The Investigators examine AST, ALT, GGT, and other metabolic parameters at baseline, as well as after 4 and 8 weeks of intervention. Sixty adults were administered either 600 mg of Panax Ginseng C.A. Mey Extract or a placebo each day for 8 weeks;

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • ALT ranging from upper limit of reference to three times of upper limit

Exclusion criteria

  • Abnormal liver or renal function (i.e., serum aminotransferase activity > 3 times of upper limit of reference range and serum creatinine concentrations > 1.2 mg/dL)
  • Diabetes (diagnosed clinically or fasting glucose level > 126 mg/dL)
  • History of viral hepatitis or cancer
  • Uncontrolled hypertension
  • History of serious cardiac disease such as angina or myocardial infarction
  • History of gastrectomy
  • History of medication for psychiatric disease
  • Administration of oriental medicine including herbs within the past 4 weeks

Treatment and study plan

Panax Ginseng C.A. Mey Extract group

Dietary Supplement

This group takes Panax Ginseng C.A. Mey Extract for 8 weeks

Placebo Group

Dietary Supplement

This group takes placebo for 8 weeks

Primary outcomes

  1. Alanine aminotransferase

    Time frame: 8 weeks

    Alanine aminotransferase

Secondary outcomes

  1. Aspartate aminotransferase

    Time frame: 8 weeks

    Aspartate aminotransferase

  2. Gamma-glutamyl transferase

    Time frame: 8 weeks

    Gamma-glutamyl transferase

Study contacts

Contact information is provided by the study sponsor or research team.

Sang Yeoup Lee

CONTACT

[email protected]

360-2860 ext. 055

Ye Li Lee

CONTACT

[email protected]

360-2860 ext. 055

Sponsors and collaborators

Lead sponsor

Pusan National University Yangsan Hospital

Other

Registry information

Official study title

Effect of Panax Ginseng C.A. Mey Extract on Liver Function in Adults: a Randomized, Double-blinded, Placebo-controlled Trial

Important dates

Study start
2018
Primary completion
2025
Study completion
2025
First posted
Dec 14, 2018
Registry last updated
Jun 4, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.